Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?

Microscopic evaluation of sentinel lymph nodes for metastatic melanoma relies, in part, on the use of immunohistochemical analysis to identify minute metastatic deposits that may be overlooked on routine microscopy. At present S100 protein is widely used in this role, in large part for its superior...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Applied immunohistochemistry & molecular morphology 2016-01, Vol.24 (1), p.26-29
Hauptverfasser: Vrotsos, Elena, Alexis, John
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 29
container_issue 1
container_start_page 26
container_title Applied immunohistochemistry & molecular morphology
container_volume 24
creator Vrotsos, Elena
Alexis, John
description Microscopic evaluation of sentinel lymph nodes for metastatic melanoma relies, in part, on the use of immunohistochemical analysis to identify minute metastatic deposits that may be overlooked on routine microscopy. At present S100 protein is widely used in this role, in large part for its superior sensitivity; however, interpretation is hampered by the presence of benign S100 protein-positive cellular elements present in every lymph node, leading to reduced specificity and consequent difficulties in interpretation. In recent years, multiple melanocytic markers have emerged that promise superior sensitivity and specificity, including KBA.62 and SOX-10. SOX-10 shows a nuclear pattern of staining. In normal tissue it is expressed in Schwann cells, melanocytes, and myoepithelial cells of salivary, bronchial, and mammary glands. KBA.62 is also specific except for staining of endothelial cells and shows a membranous staining pattern. This study was undertaken to determine whether KBA.62 or SOX-10 could equal (or surpass) the sensitivity of S100 protein while offering superior specificity in the immunohistochemical evaluation of sentinel lymph nodes for metastatic melanoma. In this study we performed immunohistochemical stains for S100 protein, Sox-10, and KBA.62 on 50 lymph nodes with proven metastatic melanoma. SOX-10 detected all cases of metastatic melanoma (50 of 50 cases; 100%) compared with S100 protein (48 of 50 cases; 96%) and KBA.62 (37 of 50 cases; 74%). There was no "background" staining of normal cellular elements with SOX-10 or KBA.62. In contrast, S100 protein was expressed in scattered dendritic interdigitating reticulum cells in the paracortex of lymph nodes, showing cytoplasmic and nuclear positivity, sometimes posing significant difficulty in differentiating benign reticulum cells from single cell metastatic melanoma. Our findings suggest that SOX-10 may be superior to S100 protein for identifying metastatic melanoma in a lymph node. KBA.62 was less sensitive than either marker, although more specific than S100 protein.
doi_str_mv 10.1097/PAI.0000000000000146
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808653440</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1744664074</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-2800ef66383e5f6c828486d33f2d48c1d9301d935831694667ecdcd257515f1d3</originalsourceid><addsrcrecordid>eNqFUdtq20AQXUpKc2n_IIR9zIucmb1p_VRc4zQmzoW6hb6J7WqEFSSto5UCgX581-RCyUuGYWYezpwzzGHsGGGCMM3PbmfLCfwfqMwHdoBaykyBtnu7WWEmAM0-O4zxDkAIqdQnti-0QRTKHLC_c9fx9c3vDIGHnl9-m02M4D9o2zhPfI0A_LYPA9UdT7ls27ELmzoOwW-orb1r-OLBNaMb6tDxUPE1dUPdUcNXj-12w69DSZFXifmKBheHhPNpbFwXWvf1M_tYuSbSl-d-xH6dL37OL7LVzfflfLbKvEIYMmEBqDJGWkm6Mt4Kq6wppaxEqazHciphV7SVaKbKmJx86Uuhc426wlIesdMn3m0f7keKQ9HW0VOTzqAwxgItWKPTa-B9aK6SgIJcJah6gvo-xNhTVWz7unX9Y4FQ7CwqkkXFW4vS2smzwvinpfJ16cUT-Q-JtYia</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1744664074</pqid></control><display><type>article</type><title>Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><creator>Vrotsos, Elena ; Alexis, John</creator><creatorcontrib>Vrotsos, Elena ; Alexis, John</creatorcontrib><description>Microscopic evaluation of sentinel lymph nodes for metastatic melanoma relies, in part, on the use of immunohistochemical analysis to identify minute metastatic deposits that may be overlooked on routine microscopy. At present S100 protein is widely used in this role, in large part for its superior sensitivity; however, interpretation is hampered by the presence of benign S100 protein-positive cellular elements present in every lymph node, leading to reduced specificity and consequent difficulties in interpretation. In recent years, multiple melanocytic markers have emerged that promise superior sensitivity and specificity, including KBA.62 and SOX-10. SOX-10 shows a nuclear pattern of staining. In normal tissue it is expressed in Schwann cells, melanocytes, and myoepithelial cells of salivary, bronchial, and mammary glands. KBA.62 is also specific except for staining of endothelial cells and shows a membranous staining pattern. This study was undertaken to determine whether KBA.62 or SOX-10 could equal (or surpass) the sensitivity of S100 protein while offering superior specificity in the immunohistochemical evaluation of sentinel lymph nodes for metastatic melanoma. In this study we performed immunohistochemical stains for S100 protein, Sox-10, and KBA.62 on 50 lymph nodes with proven metastatic melanoma. SOX-10 detected all cases of metastatic melanoma (50 of 50 cases; 100%) compared with S100 protein (48 of 50 cases; 96%) and KBA.62 (37 of 50 cases; 74%). There was no "background" staining of normal cellular elements with SOX-10 or KBA.62. In contrast, S100 protein was expressed in scattered dendritic interdigitating reticulum cells in the paracortex of lymph nodes, showing cytoplasmic and nuclear positivity, sometimes posing significant difficulty in differentiating benign reticulum cells from single cell metastatic melanoma. Our findings suggest that SOX-10 may be superior to S100 protein for identifying metastatic melanoma in a lymph node. KBA.62 was less sensitive than either marker, although more specific than S100 protein.</description><identifier>ISSN: 1541-2016</identifier><identifier>EISSN: 1533-4058</identifier><identifier>DOI: 10.1097/PAI.0000000000000146</identifier><identifier>PMID: 25611246</identifier><language>eng</language><publisher>United States</publisher><subject>Antibodies, Monoclonal - genetics ; Biomarkers, Tumor - genetics ; Gene Expression ; Humans ; Immunohistochemistry ; Lymph Nodes - metabolism ; Lymph Nodes - pathology ; Lymphatic Metastasis ; Melanocytes - metabolism ; Melanocytes - pathology ; Melanoma - diagnosis ; Melanoma - genetics ; Melanoma - pathology ; Prognosis ; S100 Proteins - genetics ; Sensitivity and Specificity ; Skin Neoplasms - diagnosis ; Skin Neoplasms - genetics ; Skin Neoplasms - pathology ; SOXE Transcription Factors - genetics</subject><ispartof>Applied immunohistochemistry &amp; molecular morphology, 2016-01, Vol.24 (1), p.26-29</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-2800ef66383e5f6c828486d33f2d48c1d9301d935831694667ecdcd257515f1d3</citedby><cites>FETCH-LOGICAL-c410t-2800ef66383e5f6c828486d33f2d48c1d9301d935831694667ecdcd257515f1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25611246$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vrotsos, Elena</creatorcontrib><creatorcontrib>Alexis, John</creatorcontrib><title>Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?</title><title>Applied immunohistochemistry &amp; molecular morphology</title><addtitle>Appl Immunohistochem Mol Morphol</addtitle><description>Microscopic evaluation of sentinel lymph nodes for metastatic melanoma relies, in part, on the use of immunohistochemical analysis to identify minute metastatic deposits that may be overlooked on routine microscopy. At present S100 protein is widely used in this role, in large part for its superior sensitivity; however, interpretation is hampered by the presence of benign S100 protein-positive cellular elements present in every lymph node, leading to reduced specificity and consequent difficulties in interpretation. In recent years, multiple melanocytic markers have emerged that promise superior sensitivity and specificity, including KBA.62 and SOX-10. SOX-10 shows a nuclear pattern of staining. In normal tissue it is expressed in Schwann cells, melanocytes, and myoepithelial cells of salivary, bronchial, and mammary glands. KBA.62 is also specific except for staining of endothelial cells and shows a membranous staining pattern. This study was undertaken to determine whether KBA.62 or SOX-10 could equal (or surpass) the sensitivity of S100 protein while offering superior specificity in the immunohistochemical evaluation of sentinel lymph nodes for metastatic melanoma. In this study we performed immunohistochemical stains for S100 protein, Sox-10, and KBA.62 on 50 lymph nodes with proven metastatic melanoma. SOX-10 detected all cases of metastatic melanoma (50 of 50 cases; 100%) compared with S100 protein (48 of 50 cases; 96%) and KBA.62 (37 of 50 cases; 74%). There was no "background" staining of normal cellular elements with SOX-10 or KBA.62. In contrast, S100 protein was expressed in scattered dendritic interdigitating reticulum cells in the paracortex of lymph nodes, showing cytoplasmic and nuclear positivity, sometimes posing significant difficulty in differentiating benign reticulum cells from single cell metastatic melanoma. Our findings suggest that SOX-10 may be superior to S100 protein for identifying metastatic melanoma in a lymph node. KBA.62 was less sensitive than either marker, although more specific than S100 protein.</description><subject>Antibodies, Monoclonal - genetics</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Lymph Nodes - metabolism</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphatic Metastasis</subject><subject>Melanocytes - metabolism</subject><subject>Melanocytes - pathology</subject><subject>Melanoma - diagnosis</subject><subject>Melanoma - genetics</subject><subject>Melanoma - pathology</subject><subject>Prognosis</subject><subject>S100 Proteins - genetics</subject><subject>Sensitivity and Specificity</subject><subject>Skin Neoplasms - diagnosis</subject><subject>Skin Neoplasms - genetics</subject><subject>Skin Neoplasms - pathology</subject><subject>SOXE Transcription Factors - genetics</subject><issn>1541-2016</issn><issn>1533-4058</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUdtq20AQXUpKc2n_IIR9zIucmb1p_VRc4zQmzoW6hb6J7WqEFSSto5UCgX581-RCyUuGYWYezpwzzGHsGGGCMM3PbmfLCfwfqMwHdoBaykyBtnu7WWEmAM0-O4zxDkAIqdQnti-0QRTKHLC_c9fx9c3vDIGHnl9-m02M4D9o2zhPfI0A_LYPA9UdT7ls27ELmzoOwW-orb1r-OLBNaMb6tDxUPE1dUPdUcNXj-12w69DSZFXifmKBheHhPNpbFwXWvf1M_tYuSbSl-d-xH6dL37OL7LVzfflfLbKvEIYMmEBqDJGWkm6Mt4Kq6wppaxEqazHciphV7SVaKbKmJx86Uuhc426wlIesdMn3m0f7keKQ9HW0VOTzqAwxgItWKPTa-B9aK6SgIJcJah6gvo-xNhTVWz7unX9Y4FQ7CwqkkXFW4vS2smzwvinpfJ16cUT-Q-JtYia</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Vrotsos, Elena</creator><creator>Alexis, John</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20160101</creationdate><title>Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?</title><author>Vrotsos, Elena ; Alexis, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-2800ef66383e5f6c828486d33f2d48c1d9301d935831694667ecdcd257515f1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antibodies, Monoclonal - genetics</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Lymph Nodes - metabolism</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphatic Metastasis</topic><topic>Melanocytes - metabolism</topic><topic>Melanocytes - pathology</topic><topic>Melanoma - diagnosis</topic><topic>Melanoma - genetics</topic><topic>Melanoma - pathology</topic><topic>Prognosis</topic><topic>S100 Proteins - genetics</topic><topic>Sensitivity and Specificity</topic><topic>Skin Neoplasms - diagnosis</topic><topic>Skin Neoplasms - genetics</topic><topic>Skin Neoplasms - pathology</topic><topic>SOXE Transcription Factors - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vrotsos, Elena</creatorcontrib><creatorcontrib>Alexis, John</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Applied immunohistochemistry &amp; molecular morphology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vrotsos, Elena</au><au>Alexis, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?</atitle><jtitle>Applied immunohistochemistry &amp; molecular morphology</jtitle><addtitle>Appl Immunohistochem Mol Morphol</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>24</volume><issue>1</issue><spage>26</spage><epage>29</epage><pages>26-29</pages><issn>1541-2016</issn><eissn>1533-4058</eissn><abstract>Microscopic evaluation of sentinel lymph nodes for metastatic melanoma relies, in part, on the use of immunohistochemical analysis to identify minute metastatic deposits that may be overlooked on routine microscopy. At present S100 protein is widely used in this role, in large part for its superior sensitivity; however, interpretation is hampered by the presence of benign S100 protein-positive cellular elements present in every lymph node, leading to reduced specificity and consequent difficulties in interpretation. In recent years, multiple melanocytic markers have emerged that promise superior sensitivity and specificity, including KBA.62 and SOX-10. SOX-10 shows a nuclear pattern of staining. In normal tissue it is expressed in Schwann cells, melanocytes, and myoepithelial cells of salivary, bronchial, and mammary glands. KBA.62 is also specific except for staining of endothelial cells and shows a membranous staining pattern. This study was undertaken to determine whether KBA.62 or SOX-10 could equal (or surpass) the sensitivity of S100 protein while offering superior specificity in the immunohistochemical evaluation of sentinel lymph nodes for metastatic melanoma. In this study we performed immunohistochemical stains for S100 protein, Sox-10, and KBA.62 on 50 lymph nodes with proven metastatic melanoma. SOX-10 detected all cases of metastatic melanoma (50 of 50 cases; 100%) compared with S100 protein (48 of 50 cases; 96%) and KBA.62 (37 of 50 cases; 74%). There was no "background" staining of normal cellular elements with SOX-10 or KBA.62. In contrast, S100 protein was expressed in scattered dendritic interdigitating reticulum cells in the paracortex of lymph nodes, showing cytoplasmic and nuclear positivity, sometimes posing significant difficulty in differentiating benign reticulum cells from single cell metastatic melanoma. Our findings suggest that SOX-10 may be superior to S100 protein for identifying metastatic melanoma in a lymph node. KBA.62 was less sensitive than either marker, although more specific than S100 protein.</abstract><cop>United States</cop><pmid>25611246</pmid><doi>10.1097/PAI.0000000000000146</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1541-2016
ispartof Applied immunohistochemistry & molecular morphology, 2016-01, Vol.24 (1), p.26-29
issn 1541-2016
1533-4058
language eng
recordid cdi_proquest_miscellaneous_1808653440
source Journals@Ovid Ovid Autoload; MEDLINE
subjects Antibodies, Monoclonal - genetics
Biomarkers, Tumor - genetics
Gene Expression
Humans
Immunohistochemistry
Lymph Nodes - metabolism
Lymph Nodes - pathology
Lymphatic Metastasis
Melanocytes - metabolism
Melanocytes - pathology
Melanoma - diagnosis
Melanoma - genetics
Melanoma - pathology
Prognosis
S100 Proteins - genetics
Sensitivity and Specificity
Skin Neoplasms - diagnosis
Skin Neoplasms - genetics
Skin Neoplasms - pathology
SOXE Transcription Factors - genetics
title Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T01%3A28%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20SOX-10%20or%20KBA.62%20Replace%20S100%20Protein%20in%20Immunohistochemical%20Evaluation%20of%20Sentinel%20Lymph%20Nodes%20for%20Metastatic%20Melanoma?&rft.jtitle=Applied%20immunohistochemistry%20&%20molecular%20morphology&rft.au=Vrotsos,%20Elena&rft.date=2016-01-01&rft.volume=24&rft.issue=1&rft.spage=26&rft.epage=29&rft.pages=26-29&rft.issn=1541-2016&rft.eissn=1533-4058&rft_id=info:doi/10.1097/PAI.0000000000000146&rft_dat=%3Cproquest_cross%3E1744664074%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1744664074&rft_id=info:pmid/25611246&rfr_iscdi=true